Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2025 and 2026.
Financials
Financial year 2026
IMMOMED from Middelkerke, company number BE0451808974, closed financial year 2026 with a result of € -7,757 after tax. For that financial year IMMOMED recorded a gross margin of € -644 and equity of € 132,374. Compared with financial year 2025, the result moved from € -7,246 to € -7,757. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 2, 2026.
€ 132,374
▼ 6% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -7,757
▼ 7 % more loss than in 2025
Profit after tax over the fiscal year.
€ 20,189
▼ 4% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -65,941.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 1,010
▲ 76% vs 2025
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 2,362 | € -1,142 | € 218 | € -644 | ▼ € 862 |
| Profit after taxes | € -10,262 | € -13,765 | € -7,246 | € -7,757 | ▼ € 511 |
| Equity | € 161,142 | € 147,376 | € 140,130 | € 132,374 | ▼ 6% |
| Total debts | € 14,688 | € 16,295 | € 15,680 | € 16,155 | ▲ 3% |
| Cash | € 104,552 | € 21,544 | € 20,987 | € 20,189 | ▼ 4% |
| Land & buildings | € 61,801 | € 56,398 | € 50,994 | € 45,591 | ▼ 11% |
| Retained profit | € -37,173 | € -50,938 | € -58,184 | € -65,941 | ▼ € 7,757 |
| Balance sheet total | € 175,829 | € 163,672 | € 155,811 | € 148,529 | ▼ 5% |
Key figures of IMMOMED, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 30 January 2028.
What happened to IMMOMED?
What happened at IMMOMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Magda Ringoet stepped down as director. NBB
- Lauranne Pierret stepped down as director. NBB
- Johan Pierret stepped down as director. NBB
- Celine Pierret stepped down as director. NBB
- New annual accounts for financial year 2026: loss of € 7,757. Source: NBB ↗
- Magda Ringoet became a director. NBB
- Lauranne Pierret became a director. NBB
- Johan Pierret became a director. NBB
In short
From € 10,262 loss in 2023 to € 7,757 loss in 2026.
Management
Directors
According to the 2026 annual accounts
Magda Ringoet
Director
since 2023 · until 2029
since 2023 · until 2029
Johan Pierret
Director
since 2023 · until 2029
Celine Pierret
Director
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Mezenlaan 3 box 71
8430 Middelkerke
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0451.808.974
- VAT number
- BE 0451.808.974
- Registered office
- Mezenlaan 3 bus 71, 8430 Middelkerke
- Names & denominations
- IMMOMED
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 December 1993
- Peppol
- Active · Active since 19 Sept 2025